Influenza vaccination uptake among high-risk target groups and health care workers in Spain and change from 2017 to 2020
| Autor: | Rodrigo Jiménez-García, José J. Zamorano-León, Sara Sanz-Rojo, Napoleón Pérez-Farinós, Javier de Miguel-Díez, Ana López-de-Andrés |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Influenza vaccine Health Personnel Disease Logistic regression Diabetes mellitus Environmental health Influenza Human Health care Pandemic Humans Medicine National Health Interview Survey Pandemics Aged General Veterinary General Immunology and Microbiology SARS-CoV-2 business.industry Vaccination Public Health Environmental and Occupational Health COVID-19 medicine.disease Cross-Sectional Studies Infectious Diseases Spain Molecular Medicine Female business |
| Zdroj: | Vaccine. 39:7012-7020 |
| ISSN: | 0264-410X |
| DOI: | 10.1016/j.vaccine.2021.10.059 |
| Popis: | Using the 2020 European Health Survey for Spain (EHSS2020), which ran from July 2019 to July 2020, we aimed to describe influenza vaccination uptake among the following target groups; individuals aged ≥65 years, health care workers (HCWs), and persons with high-risk chronic medical conditions. We analyzed changes in uptake since the previous Spanish National Health Interview Survey conducted in 2017 and identified variables associated with vaccine uptake.We performed a cross-sectional study. The primary study variable was the self-reported uptake of influenza vaccine in the previous year. We analyzed sex, age, country of birth, and being an HCW. We identified participants with self-reported respiratory diseases, cardiovascular disease, diabetes, cancer, and cerebrovascular diseases. Multivariable logistic regression was applied to assess changes over time and to identify variables associated with vaccination in target groups.Uptake was 19.2% in 22,072 participants aged ≥15 years. Uptake was 54.4% for those aged ≥65 years, 41.6% for those with a high-risk medical condition, and 26.53% among HCWs. Uptake by disease was 52.1% for cerebrovascular diseases, 51.3% for cardiovascular diseases, 48.3% for diabetes, 46.1% for cancer, and 36.2% for respiratory diseases. No significant improvement has been observed since 2017 in any target group, except for participants with cancer, whose uptake increased from 33.2% to 46.1%(p 0.001). The variables that significantly increased the probability of reporting vaccine uptake were female sex, age ≥35 years, being born in Spain, self-reported respiratory or cardiovascular diseases, diabetes, cancer, and being a HCW.Influenza vaccination uptake among target groups in Spain is below desirable levels and has not improved significantly since 2017. Older age, female sex, and being born in Spain are positive predictors of vaccine uptake. The COVID-19 pandemic highlights the urgent need to implement new strategies to increase influenza vaccine uptake. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect